Curemax Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Nalagarh, Himachal Pradesh, India, established in 2024.
2024 Nalagarh, Himachal Pradesh, India Active
Last Updated:
Access Report
About Curemax Pharmaceuticals Private Limited

Curemax Pharmaceuticals Private Limited, a active private limited company, was established on 20 June 2024 in Nalagarh, Himachal Pradesh, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000HP2024PTC010965. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Khushbu Singh (Director), Aaditya Kashyap (Director). Its latest AGM occurred on 25 December 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 1 , Industrial, Area, Bhatoli Kalan,, Nalagarh, Himachal Pradesh, 173205.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000HP2024PTC010965

  • Registration Number

    010965

  • Incorporation Date

    20 June 2024

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Curemax Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Curemax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Curemax Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Khushbu Singh Director 20 Jun 2024 Current
Aaditya Kashyap Director 20 Jun 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Curemax Pharmaceuticals.

Enhance accessibility to Curemax Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Curemax Pharmaceuticals revenue growth over time
Curemax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Curemax Pharmaceuticals?

Unlock access to Curemax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Curemax Pharmaceuticals?

Unlock and access historical data on people associated with Curemax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curemax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curemax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Curemax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Curemax Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Dec 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Curemax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh. was documented.

  • Director Appointment

    The activity Khushbu Singh was appointed as a Director was appointed as a Director on 20 Jun 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    Aaditya Kashyap was appointed as a Director was appointed as a Director on 20 Jun 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Company Incorporation

    Curemax Pharmaceuticals Private Limited was registered on 20 Jun 2024 with Roc Himachal Pradesh & aged 1 year 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Curemax Pharmaceuticals Private Limited?

The CIN of Curemax Pharmaceuticals Private Limited is U21000HP2024PTC010965.

Where is Curemax Pharmaceuticals Private Limited headquartered?

Curemax Pharmaceuticals Private Limited is headquartered at Plot No. 1 , Industrial, Area, Bhatoli Kalan,, Nalagarh, Himachal Pradesh, 173205.

When was Curemax Pharmaceuticals Private Limited incorporated?

Curemax Pharmaceuticals Private Limited was incorporated on 20 June 2024.

Who are the current directors of Curemax Pharmaceuticals Private Limited?

The current directors of Curemax Pharmaceuticals Private Limited are

What is the primary industry of Curemax Pharmaceuticals Private Limited?

The primary industry of Curemax Pharmaceuticals Private Limited is Paper.

Is Curemax Pharmaceuticals Private Limited a listed company?

Curemax Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Curemax Pharmaceuticals Private Limited?

The authorized capital of Curemax Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available